Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer

SIMPLE SUMMARY: Breast cancer is one of the leading causes of death for women worldwide. Patients whose tumors express estrogen receptor α (ERα) are the vast majority and are mostly treated with targeted endocrine therapy. However, resistance development poses an urgent clinical problem and the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgoni, Simone, Sofyalı, Emre, Soleimani, Maryam, Wilhelm, Heike, Müller-Decker, Karin, Will, Rainer, Noronha, Ashish, Beumers, Lukas, Verschure, Pernette J., Yarden, Yosef, Magnani, Luca, van Kampen, Antoine H.C., Moerland, Perry D., Wiemann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650760/
https://www.ncbi.nlm.nih.gov/pubmed/33050633
http://dx.doi.org/10.3390/cancers12102918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650760/
https://www.ncbi.nlm.nih.gov/pubmed/33050633
http://dx.doi.org/10.3390/cancers12102918

Ejemplares similares